Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2015 2
2016 3
2017 2
2019 1
2020 1
2022 1
2023 4
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Diakoulakis
Page 1
An inter-specialty cancer training programme curriculum for Europe.
Benstead K, Brandl A, Brouwers T, Civera J, Collen S, Csaba DL, De Munter J, Dewitte M, Diez de Los Rios C, Dodlek N, Eriksen JG, Forget P, Gasparatto C, Geissler J, Hall C, Juan A, Kalz M, Kelly R, Klis G, Kulaksız T, Lecoq C, Marangoni F, McInally W, Oliver K, Popovics M, Poulios C, Price R, Rollo I, Romeo S, Steinbacher J, Sulosaari V, O'Higgins N. Benstead K, et al. Eur J Surg Oncol. 2023 Sep;49(9):106989. doi: 10.1016/j.ejso.2023.106989. Epub 2023 Jul 28. Eur J Surg Oncol. 2023. PMID: 37556988 Free article. Review.
Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
D'Amico F, Gomollón F, Bamias G, Magro F, Targownik L, Leitner C, Heatta-Speicher T, Michelena N, Kolterer S, Lapthorn J, Kauffman L, Dignass A; IBD PODCAST investigators. D'Amico F, et al. United European Gastroenterol J. 2024 Jul;12(6):705-716. doi: 10.1002/ueg2.12572. Epub 2024 May 11. United European Gastroenterol J. 2024. PMID: 38733307 Free PMC article.
RESULTS: 2185 patients (Crohn's disease: n = 1,108, UC: n = 1077) with a mean (SD) age of 44.0 (14.8) years and mean (SD) disease duration of 12.4 (9.2) years were included (52.2% male). ...
RESULTS: 2185 patients (Crohn's disease: n = 1,108, UC: n = 1077) with a mean (SD) age of 44.0 (14.8) years and mean (SD) dise …
Current staging and prognostic factors in melanoma.
Bartlett EK, Karakousis GC. Bartlett EK, et al. Surg Oncol Clin N Am. 2015 Apr;24(2):215-27. doi: 10.1016/j.soc.2014.12.001. Surg Oncol Clin N Am. 2015. PMID: 25769707 Review.
Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
Fares J, Summer R, Loizidis G. Fares J, et al. Clin Rheumatol. 2024 Jan;43(1):325-338. doi: 10.1007/s10067-023-06801-7. Epub 2023 Nov 6. Clin Rheumatol. 2024. PMID: 37930595

RA-HLD patients exhibited higher statin initiation (27.4%) than DM/PM-HLD patients (17.91%, p < 0.0001). Notably, DM/PM-HLD statin users (n = 311) presented a reduced mortality rate (75 deaths/1000/year) compared to non-users (n = 661) with 147 deaths/1000/year (

RA-HLD patients exhibited higher statin initiation (27.4%) than DM/PM-HLD patients (17.91%, p < 0.0001). Notably, DM/PM-HLD statin users

Radiation, Lymph Node Dissection, or Both: Management of Lymph Node Micrometastases from Merkel Cell Carcinoma.
Ma KL, Sharon CE, Tortorello GN, Perry NJ, Keele LJ, Lukens JN, Karakousis GC, Miura JT. Ma KL, et al. Ann Surg Oncol. 2023 Jul;30(7):4345-4355. doi: 10.1245/s10434-023-13437-z. Epub 2023 Apr 27. Ann Surg Oncol. 2023. PMID: 37106277
RESULTS: A total of 962 patients were included [median (interquartile range) age, 74 (67-80) years, 662 (68.8%) male patients, 926 (96.3%) white patients]. The majority (63%, n = 606) had a CLND only, while 18% (n = 173) had RT only, and 19% (n = 183) had bot …
RESULTS: A total of 962 patients were included [median (interquartile range) age, 74 (67-80) years, 662 (68.8%) male patients, 926 (96.3%) w …
Implications of Lymph Node Evaluation in the Management of Resectable Soft Tissue Sarcoma.
Ecker BL, Peters MG, McMillan MT, Sinnamon AJ, Zhang PJ, Kelz RR, Roses RE, Drebin JA, Fraker DL, Karakousis GC. Ecker BL, et al. Ann Surg Oncol. 2017 Feb;24(2):425-433. doi: 10.1245/s10434-016-5641-1. Epub 2016 Oct 26. Ann Surg Oncol. 2017. PMID: 27785659
Omission of nodal evaluation was significantly associated with risk of death (reference: N0; N+: hazard ratio [HR] 1.46, 95% confidence interval [CI] 1.11-1.91; NX: OR 1.18, 95% CI 1.00-1.40). After propensity score matching, there was a significant difference in median OS …
Omission of nodal evaluation was significantly associated with risk of death (reference: N0; N+: hazard ratio [HR] 1.46, 95% confiden …
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis.
Kwak M, Song Y, Gimotty PA, Farrow NE, Tieniber AD, Davick JG, Tortorello GN, Beasley GM, Slingluff CL Jr, Karakousis GC. Kwak M, et al. Ann Surg Oncol. 2019 Nov;26(12):3962-3971. doi: 10.1245/s10434-019-07694-0. Epub 2019 Aug 7. Ann Surg Oncol. 2019. PMID: 31392529 Free PMC article.

In the subgroup of patients with one cLN, the classification tree identified two groups with < 10% risk of additional pLNs: (1) Breslow thickness > 6.55 mm (n = 17); and (2) if unknown primary or Breslow thickness 6.55 mm, then LN diameter > 1.8 cm in the inguinal

In the subgroup of patients with one cLN, the classification tree identified two groups with < 10% risk of additional pLNs: (1) Breslow t

14 results